May 15, 2018ATXA Therapeutics Secures €2.5m EU Funding for Novel Pulmonary Arterial Hypertension TherapyDUBLIN, IRELAND – May 15, 2018 – ATXA Therapeutics Limited, an Irish company developing novel therapeutic drugs for the treatment of...
May 10, 2018Presidential Reception celebrating Female Entrepreneurship, Innovation, Creativity & SustainableDUBLIN, IRELAND – May 10, 2018 – Founder & Chief Scientific Officer of ATXA Therapeutics, Prof. Therese Kinsella, attended a reception...